Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Stroke. 2015 Dec 22;47(2):383–389. doi: 10.1161/STROKEAHA.115.010405

Table 3. Associations of exhaled carbon monoxide and incident stroke/TIA.

Whole sample (N=3313)
CO ≤4 ppm p value CO >4 and ≤5 ppm p value CO >5 ppm p value p for trend
Model 1, HR (95% CI) Referent -- 1.67 (1.20-2.32) 0.0022 1.97 (1.41-2.76) <0.0001 <0.0001
Model 2, HR (95% CI) Referent -- 1.60 (1.15-2.23) 0.0053 1.43 (0.96-2.14) 0.08 0.04
Model 3, HR (95% CI) Referent -- 1.57 (1.12-2.20) 0.0083 1.45 (0.97-2.17) 0.07 0.04
Nonsmokers (N=2819)
Model 1, HR (95% CI) Referent -- 1.69 (1.21-2.35) 0.0019 1.63 (1.09-2.44) 0.02 0.0056
Model 2, HR (95% CI) Referent -- 1.68 (1.20-2.35) 0.0025 1.55 (1.03-2.33) 0.04 0.01
Model 3, HR (95% CI) Referent -- 1.66 (1.18-2.34) 0.0036 1.57 (1.04-2.38) 0.03 0.01

TIA indicates transient ischemic attack; CO, carbon monoxide; ppm, parts per million; HR, hazard ratio; CI, confidence interval.

HR represents the relative hazard for each CO category compared with the referent.

Model 1 was adjusted for age and sex.

Model 2 was additionally adjusted for systolic blood pressure, hypertension treatment status, diabetes, total/HDL cholesterol, body mass index, smoking, prevalent cardiovascular disease, prevalent atrial fibrillation.

Model 3 was additionally adjusted for log-BNP and log-CRP. N=3189 for the whole sample and N=2715 for nonsmokers.